Literature DB >> 22794283

Complications of brain tumors and their treatment.

Jill Lacy1, Hamid Saadati, James B Yu.   

Abstract

The diverse medical and neurologic complications of central nervous system (CNS) neoplasms or their treatment cause significant morbidity and mortality. Thus, their recognition and appropriate management by all members of the interdisciplinary team engaged in the care of patients with brain tumors is essential in optimizing quality of life and extending survival. Recognition of the acute, early delayed, and late complications of brain irradiation is essential to optimize management and mitigate their clinical impact.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22794283     DOI： 10.1016/j.hoc.2012.04.007

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  13 in total

Review 1.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

Review 2.  Managing Disease and Therapy-Related Complications in Patients with Central Nervous System Tumors.

Authors:  Jeffrey J Raizer; Karan S Dixit
Journal:  Curr Treat Options Oncol       Date:  2015-08

Review 3.  Glioblastoma: Overview of Disease and Treatment.

Authors:  Mary Elizabeth Davis
Journal:  Clin J Oncol Nurs       Date:  2016-10-01       Impact factor: 1.027

Review 4.  Abnormal movements in critical care patients with brain injury: a diagnostic approach.

Authors:  Yousef Hannawi; Michael S Abers; Romergryko G Geocadin; Marek A Mirski
Journal:  Crit Care       Date:  2016-03-14       Impact factor: 9.097

5.  Epidemiologic and histologic characteristics of CNS lesions: a 20-year experience of a tertiary center in Lebanon.

Authors:  Roland Eid; Stephanie Hage; Ingrid Antonios; Rita Moussa; Makram Khoury; Fady Ghassan Haddad; Hampig Raphael Kourie; Carole Kesrouani; Claude Ghorra; Gerard Abadjian; Joseph Kattan
Journal:  CNS Oncol       Date:  2020-06-30

6.  Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study.

Authors:  Hongqing Zhuang; Hongxia Zhuang; Siyu Shi; Yuxia Wang
Journal:  Onco Targets Ther       Date:  2019-10-11       Impact factor: 4.147

7.  Immunohistochemical Expression of Epidermal Growth Factor Receptor in Astrocytic Tumors in Iraqi Patients.

Authors:  Mohanad Mundher Abdulghani; Mohamad Natiq Abbas; Wafaa Redha Mohammed
Journal:  Open Access Maced J Med Sci       Date:  2019-10-11

8.  Orthotopic models of pediatric brain tumors in zebrafish.

Authors:  C J Eden; B Ju; M Murugesan; T N Phoenix; B Nimmervoll; Y Tong; D W Ellison; D Finkelstein; K Wright; N Boulos; J Dapper; R Thiruvenkatam; C A Lessman; M R Taylor; R J Gilbertson
Journal:  Oncogene       Date:  2014-04-21       Impact factor: 9.867

9.  A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis.

Authors:  Hongqing Zhuang; Xiangkun Yuan; Yi Zheng; Xubin Li; Joe Y Chang; Junjie Wang; Xiaoguang Wang; Zhiyong Yuan; Ping Wang
Journal:  Sci Rep       Date:  2016-04-12       Impact factor: 4.379

10.  Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.

Authors:  Hongqing Zhuang; Xiangkun Yuan; Joe Y Chang; Yongchun Song; Junjie Wang; Zhiyong Yuan; Xiaoguang Wang; Ping Wang
Journal:  Oncotarget       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.